Irinotecan

ایرینوتکان

⚠ Unverified

🎗️ Antineoplastic And Immunomodulating AgentsTopoisomerase I inhibitor

Market / country: 🇺🇸 USA

Camptosar (US)

🧮 Dose calculator

Colorectal cancer · Regimen source: FDA Irinotecan · 2.1, Table 1

  • • Only under an oncologist in an equipped centre. Calculator = label mg/m² × BSA (Mosteller); protocol, cycle interval and adjustment for CBC and renal/hepatic function rest with the oncology team. FDA Irinotecan · 2.1
  • • Single-agent weekly is also 125 mg/m² (days 1, 8, 15, 22 every 6 weeks). UGT1A1*28 homozygous: reduce by one dose level. FDA Irinotecan · 2.2, Table 3FDA Irinotecan · 2.3

Enter age and weight.

🛡️ Safety & information

Contraindications

Warnings

  • • Boxed warning: early (cholinergic — atropine) and late life-threatening diarrhoea (prompt loperamide); severe myelosuppression. FDA Irinotecan · Boxed Warning
  • • Higher neutropenia risk with reduced UGT1A1 activity; hypersensitivity; renal failure; pulmonary toxicity; embryo-fetal toxicity. FDA Irinotecan · 5

Formulations

👥 Special populations

  • 🤰 PregnancyDangerous / avoid

    Label: can cause fetal harm. Dangerous in pregnancy. FDA Irinotecan · 8.1

    “Risk Summary Based on findings from animal studies and its mechanism of action, Irinotecan Hydrochloride Injection can cause fetal harm when administered to a pregnant woman [see Clinical Pharmacology ( 12.1 )] .”
  • 🤱 BreastfeedingDangerous / avoid

    Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Irinotecan · 8.2

    “Because of the potential for serious adverse reactions from Irinotecan Hydrochloride Injection in the breastfed child, advise lactating women not to breastfeed during treatment with Irinotecan Hydrochloride Injection and for 7 days after the final dose.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Irinotecan · 8.4

    “The effectiveness of irinotecan in pediatric patients has not been established.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Irinotecan · 8.5

    “Patients greater than 65 years of age should be closely monitored because of a greater risk of early and late diarrhea in this population [see Clinical Pharmacology (12.3) and Adverse Reactions (6.1) ] .”
  • ⚥ Females & males of reproductive potentialUse with caution

    Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Irinotecan · 8.3

    “Contraception Irinotecan Hydrochloride Injection can cause fetal harm when administered to a pregnant woman.”

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav